Molecular Diversity and Recombination Patterns of the ORF7 (Nucleocapsid) Gene in Betaarterivirus americense Variants Circulating from Lima, Peru

This study characterizes the genetic diversity and recombination patterns of the ORF7 gene in ten PRRSV-2 strains from Lima, Peru, revealing the co-circulation of NADC34-like and VR2332-like lineages, significant amino acid substitutions in antigenic regions, and inter-lineage recombination events that underscore the need for continuous molecular surveillance to support effective disease control.

The Gist

🐷 The Story: A Genetic Detective Case in Peruvian Pig Farms

Imagine the pig farming industry in Lima, Peru, is a bustling city. In this city, there is a notorious "villain" called PRRSV (Porcine Reproductive and Respiratory Syndrome Virus). This virus is like a master of disguise; it constantly changes its costume to avoid being caught by the pigs' immune systems or the farmers' vaccines.

This study is like a team of genetic detectives (led by Dr. Rony Cotaquispe) who went into the city to catch a specific part of the virus: the Nucleocapsid (N) protein. Think of the N protein as the virus's ID card or license plate. It's a small, essential piece of the virus that helps it build its body, but it also carries the unique markings that tell us exactly which "gang" (lineage) the virus belongs to.

Here is what the detectives found:

1. Two Different Gangs in the Same Neighborhood

The researchers looked at 10 different virus samples from pig farms. They discovered that the city isn't just populated by one type of criminal; there are two distinct gangs circulating at the same time:

• Gang A (Lineage 1A): This is the "NADC34-like" gang. They are the new kids on the block, very similar to a strain known as NADC34. Eight of the 10 samples belonged to this group.
• Gang B (Lineage 5A): This is the "VR2332-like" gang. They are the old-school veterans, very similar to an older vaccine strain. Only two samples belonged to this group.

The Takeaway: The pigs in Lima are being attacked by two different versions of the virus simultaneously. This is like a city dealing with both pickpockets and burglars at the same time; you need different security measures for each.

2. The "Tattoo" Changes (Mutations)

Viruses are like copy machines that make mistakes when they reproduce. These mistakes are called mutations. The detectives found that the "Gang A" members had started getting new "tattoos" (amino acid changes) on their ID cards, specifically on the back end (the C-terminal region).

• Strain 24 was the most rebellious. It had accumulated the most changes, almost rewriting its own ID card.
• These changes happened in specific areas called Antigenic Domains. Imagine these domains as the "face" of the virus that the immune system looks at. By changing the face slightly, the virus hopes the immune system won't recognize it anymore.

3. The "Chameleon" Effect (Recombination)

This is the most exciting part of the story. The researchers found evidence of recombination.

Imagine two different viruses infecting the same pig at the same time. Inside the pig's body, their genetic instructions get mixed up, like shuffling two decks of cards. The virus then creates a new "hybrid" offspring that has the front half of Dad's deck and the back half of Mom's deck.

• The Suspect: Strain 18 (a member of Gang A) was caught red-handed.
• The Parents: It was a mix of Strain 24 (a wild Gang A virus) and VR2332 (the old vaccine virus).
• The Result: Strain 18 is a genetic chimera. It looks like Gang A in some parts, but it has a secret "vaccine" DNA segment in the middle.

Why this matters: This is like a criminal stealing a police officer's badge and wearing it. The virus is mixing its own dangerous traits with parts of the vaccine, potentially making it harder to detect or control.

4. The "Target Practice" (Epitopes)

The study also looked at B-cell epitopes. Think of these as the "bullseyes" on the virus that antibodies (the body's soldiers) aim for to kill the virus.

• The researchers mapped out where these bullseyes are located.
• They found that while some bullseyes are fixed and unchangeable (because the virus needs them to survive), others are shifting around.
• The "rebellious" strains (like Strain 24) have moved their bullseyes slightly. This means the body's soldiers might be aiming at the wrong spot, allowing the virus to slip through the defense lines.

🏁 The Final Verdict

This paper tells us that the PRRS virus in Peru is smart, adaptable, and dangerous.

1. It's not just one virus: Two different lineages are co-existing.
2. It's evolving fast: It's constantly changing its "face" to hide from immunity.
3. It's mixing and matching: It is combining wild virus DNA with vaccine DNA to create new, hybrid threats.

The Lesson for Farmers and Scientists:
You can't just use the same old vaccine or the same old test forever. The virus is playing a game of "musical chairs" with its genetics. The researchers are urging for continuous surveillance—keeping a constant eye on the virus's ID cards—to catch these new disguises before they cause a massive outbreak.

In short: The virus is changing its outfit, mixing its DNA, and trying to trick the immune system. The scientists are the fashion police, trying to spot the new trends before the virus wins the game.

Technical Summary

1. Problem Statement

Porcine Reproductive and Respiratory Syndrome (PRRS) remains a critical threat to the global swine industry, causing billions in annual economic losses. The virus exists as two species: Betaarterivirus europensis (PRRSV-1) and Betaarterivirus americense (PRRSV-2). While the ORF5 gene (encoding the GP5 envelope protein) is commonly used for phylogenetic classification, the ORF7 gene (encoding the Nucleocapsid or N protein) is highly conserved yet contains sufficient variability for strain discrimination.

The specific challenges addressed in this study include:

• Genetic Diversity: Understanding the current genetic landscape of PRRSV-2 circulating in Lima, Peru, specifically regarding the N protein.
• Recombination: Investigating whether recombination events occur within the ORF7 gene, a region often considered relatively stable, which could lead to the emergence of novel variants with altered antigenic properties.
• Antigenic Drift: Assessing how amino acid substitutions in the N protein affect B-cell epitopes, potentially impacting diagnostic accuracy and vaccine efficacy.

2. Methodology

The study analyzed ten PRRSV-2 strains isolated from pig farms in Lima, Peru. The workflow involved:

• Sample Processing: Viral RNA was extracted and converted to cDNA. A conventional RT-PCR assay using in-house primers (SKJ-F/SKJ-R) targeted the ORF7 gene, amplifying a 327 bp fragment.
• Sequencing: Bidirectional Sanger sequencing was performed on purified amplicons.
• Phylogenetic Analysis:
  • Sequences were aligned with 42 reference strains from GenBank.
  • Maximum Likelihood (ML) trees were constructed using the Jones–Taylor–Thornton (JTT) amino acid substitution model in MEGA 6 and DNAMAN v10.0.
  • Bootstrap support was calculated with 1,000 replicates.
• Antigenic and Epitope Analysis:
  • Amino acid substitutions were mapped against reference strains (NADC34-like and VR2332-like).
  • Five known antigenic domains (I–V) were evaluated.
  • Linear B-cell epitopes were predicted using the BepiPred-2.0 server (Random Forest algorithm).
• Genetic Diversity and Recombination:
  • Diversity indices (polymorphic sites, mutations) were calculated using DnaSP v6.
  • Recombination detection was performed using RDP v4.101, integrating seven algorithms (RDP, GENECONV, BootScan, MaxChi, Chimaera, SiScan, and 3Seq).
  • Statistical significance was enforced with a stringent threshold (Bonferroni-corrected $p < 0.025$) and required support from at least four independent methods.

3. Key Results

Phylogenetic Distribution

• Lineage Co-circulation: The ten isolates were divided into two distinct lineages:
  • Lineage 1A (NADC34-like): 8 strains clustered here.
  • Lineage 5A (VR2332-like): 2 strains (18 and 19) clustered here, showing 100% identity to the RespPRRS_MLV vaccine strain.
• This confirms the simultaneous circulation of genetically distinct PRRSV-2 variants in the Lima region.

Genetic Diversity and Amino Acid Substitutions

• Variability: The analysis identified 50 polymorphic nucleotide sites and 52 mutations across the dataset.
• Strain Divergence:
  • Lineage 5A strains were identical to the vaccine reference.
  • Lineage 1A strains showed significant divergence from the NADC34 reference, particularly in the C-terminal region (Antigenic Domains IV and V).
  • Strain 24 was the most divergent, accumulating five substitutions: T81I, R109S, I115F, R116S, and A119K.
  • Other strains shared specific mutations (e.g., S70G in strains 15–17; C75S and D94E in strain 20).
• Conserved Regions: Despite variability, critical structural regions like Nuclear Localization Signals (NLS-1, NLS-2) and the conserved Cysteine at position 23 (Cys23) remained unchanged.

B-Cell Epitope Prediction

• Six distinct epitope patterns (A–F) were identified, comprising nine potential B-cell epitope regions.
• Pattern A was exclusive to Lineage 5A.
• Patterns B, E, and F (associated with Lineage 1A strains 21–24) exhibited higher complexity, containing 4–5 predicted epitope sites. This suggests potential modulation of antigenic profiles within the NADC34-like sublineage.

Recombination Analysis

• Primary Event: A statistically robust recombination event was detected in Strain 18_montana2020-R.
  • Breakpoints: Nucleotides 141–414.
  • Major Parent: Strain 24_montana2020-WT (Lineage 1A, 100% similarity).
  • Minor Parent: EF536003.1 (Lineage 5A, vaccine-like VR2332, 99.3% similarity).
  • Statistical Support: Confirmed by all seven RDP algorithms with a global Bonferroni-corrected $p$-value of $1.441 \times 10^{-12}$.
• Secondary Evidence: Strain 19_montana2020 showed secondary evidence of the same event, suggesting clonal propagation of the recombinant genome rather than a new independent event.
• Phylogenetic Incongruence: Phylogenetic trees of the flanking regions (1–140, 415–523) grouped Strain 18 with Lineage 1A, while the recombinant central region (141–414) grouped it with Lineage 5A, confirming a mosaic genome structure.

4. Key Contributions

1. First Documentation of Lineage 5A in Lima: Confirms the presence of the RespPRRS_MLV-like lineage alongside the dominant NADC34-like strains in the region.
2. ORF7 Recombination: Demonstrates that recombination can occur even in the relatively conserved ORF7 gene, challenging the assumption that this region is immune to mosaic formation.
3. Antigenic Mapping: Provides a detailed map of B-cell epitope variations in Peruvian strains, highlighting that specific subclusters (strains 21–24) possess unique epitope patterns that could influence serological detection.
4. Epidemiological Insight: The detection of a recombinant strain derived from a field strain (Lineage 1A) and a vaccine-like strain (Lineage 5A) suggests potential co-infections and genetic exchange between vaccine and wild-type viruses.

5. Significance and Implications

• Vaccine Efficacy: The emergence of recombinant strains and specific amino acid substitutions in antigenic domains raises concerns about the ability of current vaccines to induce cross-protective immunity against circulating variants.
• Diagnostic Challenges: Variability in the N protein, particularly in B-cell epitopes, could lead to false negatives or reduced sensitivity in serological tests relying on N-protein antigens.
• Surveillance Strategy: The study underscores the necessity of continuous molecular surveillance that includes recombination analysis. Relying solely on point mutations or single-gene phylogenies may lead to biased evolutionary inferences.
• Control Strategies: The findings support the need for updated control strategies in the Peruvian swine industry, potentially requiring vaccines that cover both Lineage 1A and 5A, and monitoring for the spread of recombinant variants.

In conclusion, this study reveals a complex evolutionary landscape for PRRSV-2 in Peru, characterized by the co-circulation of distinct lineages, significant intra-lineage microevolution, and the generation of novel recombinant variants through the exchange of genetic material between field and vaccine-like strains.